Aprea TherapeuticsAPRE

13F holders, Q4 2025 (December 31)
22holders −1
5new positions
6sold out
1famous investor
$0.85avg. 13F price*

At the end of Q4 2025, 22 institutions reported holding Aprea Therapeutics Inc. (APRE) in their 13F filings, down 1 from Q3 2025. 5 opened new positions and 6 sold out. The largest holders were AIGH Capital Management LLC ($316K), Murchinson Ltd. ($290K) and Sphera Funds Management LTD. ($230K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Aprea Therapeutics Inc.
CUSIP
03836J201
Latest filing quarter
Q2 2026

History

Number of 13F holders

0102030 Q1 2024: 22Q1 2024Q2 2024: 27Q2 2024Q3 2024: 21Q3 2024Q4 2024: 26Q4 2024Q1 2025: 26Q1 2025Q2 2025: 23Q2 2025Q3 2025: 23Q3 2025Q4 2025: 22Q4 2025Q1 2026: 22Q1 2026Q2 2026: 27Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions5$497K
Exits6$403K

All 13F filers, Q3 2025 → Q4 2025: 623,895 shares bought and 547,234 shares sold, net +76,661 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 22 holders

AIGH Capital Management LLC 0.09% Reduce -31.3% 370,541 $316K
Murchinson Ltd. 0.18% New 340,139 $290K
Sphera Funds Management LTD. 0.05% No change 270,000 $230K
Nantahala Capital Management, LLC 0.01% No change 205,760 $176K
DRW Securities, LLC 0.01% New 120,651 $103K
Morgan Stanley 0.00% Add +17.1% 77,030 $66K
Vanguard Group Inc. 0.00% Reduce -63.3% 58,086 $50K
Citadel Advisors 0.00% New 51,041 $44K
Jane Street Group, LLC 0.00% New 46,621 $40K
Geode Capital Management, LLC 0.00% Reduce -8.2% 40,950 $35K
BNP Paribas Financial Markets 0.00% Add +59.5% 27,332 $23K
LPL Financial LLC 0.00% Add +62.3% 26,052 $22K
XTX Topco Ltd 0.00% New 24,304 $21K
HighTower Advisors, LLC 0.00% No change 13,864 $12K
BlackRock, Inc. 0.00% No change 8,504 $7K
Tower Research Capital LLC (TRC) 0.00% Add +1278.0% 7,827 $7K
Bank of America Corp. 0.00% Reduce -32.1% 3,299 $3K
UBS Group AG 0.00% Add +81933.3% 2,461 $2K
Group One Trading LLC 0.00% No change 577 $492
Osaic Holdings, Inc. 0.00% Reduce -25.0% 300 $255
WealthCollab, LLC 0.00% No change 158 $135
SBI Securities Co., Ltd. 0.00% Reduce -64.3% 15 $13

"% of holder's portfolio" is APRE's weight in each manager's 13F, not the share of Aprea Therapeutics Inc. the manager owns.